Gas exchange efficiency slopes to assess exercise tolerance in chronic obstructive pulmonary disease

• Published in: BMC pulmonary medicine Vol. 24; no. 1; pp. 550 - 11
• Main Authors: Yanagi, Hiromi, Miki, Keisuke, Koyama, Kazumi, Miyamoto, Satoshi, Mihashi, Yasuhiro, Nagata, Yuka, Hashimoto, Kazuki, Hashimoto, Hisako, Fukai, Mari, Maekura, Tomonori, Yonezawa, Rika, Sakaguchi, Shizuka, Nii, Takuro, Matsuki, Takanori, Tsujino, Kazuyuki, Kida, Hiroshi
• Format: Journal Article
• Language: English
• Published: England BioMed Central Ltd 31.10.2024; BioMed Central; BMC
• Subjects: Aged; Anaerobic threshold; Analysis; Carbon dioxide; Carbon Dioxide - metabolism; Care and treatment; Chronic obstructive pulmonary disease; Development and progression; Diagnosis; Diseases; Dyspnea; Efficiency; Evaluation; Exercise; Exercise Test; Exercise therapy; Exercise tolerance; Exercise Tolerance - physiology; Female; Gas exchange; Health aspects; Humans; Hypoxemia; Lung diseases; Lung diseases, Obstructive; Male; Middle Aged; Oxygen; Oxygen - metabolism; Oxygen consumption; Oxygen Consumption - physiology; Pathophysiology; Patient outcomes; Patients; Pulmonary Disease, Chronic Obstructive - physiopathology; Pulmonary Gas Exchange; Pulmonary rehabilitation; Rehabilitation; Retrospective Studies; Ventilatory efficiency; Japan; Oxygen; Exercise tolerance; Gas exchange; Pulmonary rehabilitation; Ventilatory efficiency; Carbon dioxide
• ISSN: 1471-2466; 1471-2466
• DOI: 10.1186/s12890-024-03312-2

In patients with chronic obstructive pulmonary disease (COPD), the clinical use of the minute ventilation-carbon dioxide production ([Formula: see text] -[Formula: see text] ) slope has been reported as a measure of exercise efficiency, but the oxygen uptake efficiency slope (OUES), i.e., the slope of oxygen uptake ([Formula: see text] ) versus the logarithmically transformed [Formula: see text] , has rarely been reported. We hypothesized that the [Formula: see text] -[Formula: see text] slope is more useful than OUES in clinical use for the pathophysiological evaluation of COPD. Then, we investigated the cardiopulmonary exercise testing parameters affecting each of these slopes in 122 patients with all Global Initiative for Chronic Obstructive Lung Disease (GOLD) COPD grades selected from our database. Compared with the GOLD I-II group (n = 51), peak [Formula: see text] (p < 0.0001), OUES (p = 0.0161), [Formula: see text] at peak exercise (p < 0.0001), and percutaneous oxygen saturation (SpO ) at peak exercise (p = 0.0004) were significantly lower in the GOLD III-IV group (n = 71). The GOLD III-IV group was divided into two groups by the exertional decrease in SpO from rest to peak exercise: 3% or less (the non-desaturation group: n = 23), or greater than 3% (the desaturation group: n = 48). OUES correlated only weakly with peak [Formula: see text] , [Formula: see text] at peak exercise, and the difference between inspired and expired mean O concentrations (ΔF ) at peak exercise, i.e., an indicator of oxygen consumption ability throughout the body, in the GOLD III-IV group with exertional hypoxemia. In contrast, the [Formula: see text] -[Formula: see text] slope was significantly correlated with ΔF at peak exercise, regardless of the COPD grade and exertional desaturation. Across all COPD stages, there was no correlation between the [Formula: see text] -[Formula: see text] slope and [Formula: see text] at peak exercise, and stepwise analysis identified peak [Formula: see text] (p = 0.0345) and ΔF (p < 0.0001) as variables with a greater effect on the [Formula: see text] -[Formula: see text] slope. The OUES may be less useful in advanced COPD with exertional hypoxemia. The [Formula: see text] -[Formula: see text] slope, which is independent of [Formula: see text] , focuses on oxygen consumption ability and exercise tolerance in COPD, regardless of the exertional hypoxemia level and COPD grade. Therefore, the [Formula: see text] -[Formula: see text] slope might be useful in establishing or evaluating tailor-made therapies for individual patient's pathologies in COPD as an indicator focusing on oxygen consumption ability.